Table 3

Risk of first venous thrombosis in 2479 relatives of 877 probands associated with thrombophilic defects

Index defect*Observation yearsRelatives with eventAnnual incidence, % (95% CI)Adjusted relative risk (95% CI)
Antithrombin deficiency, n = 60 1416 25 1.77 (1.14-2.60) 28.2 (13.5-58.6) 
Protein C deficiency, n = 91 2301 35 1.52 (1.06-2.11) 24.1 (13.7-42.4) 
Protein S deficiency, n = 94 1846 35 1.90 (1.32-2.64) 30.6 (26.9-55.3) 
High FVIII, n = 776 26 315 130 0.49 (0.41-0.51) 7.1 (4.3-11.8) 
Factor V Leiden, n = 652 18 237 89 0.49 (0.39-0.60) 7.5 (4.4-12.6) 
Prothrombin 20210G>A, n = 288 8324 28 0.34 (0.22-0.49) 5.2 (2.8-9.7) 
Index defect*Observation yearsRelatives with eventAnnual incidence, % (95% CI)Adjusted relative risk (95% CI)
Antithrombin deficiency, n = 60 1416 25 1.77 (1.14-2.60) 28.2 (13.5-58.6) 
Protein C deficiency, n = 91 2301 35 1.52 (1.06-2.11) 24.1 (13.7-42.4) 
Protein S deficiency, n = 94 1846 35 1.90 (1.32-2.64) 30.6 (26.9-55.3) 
High FVIII, n = 776 26 315 130 0.49 (0.41-0.51) 7.1 (4.3-11.8) 
Factor V Leiden, n = 652 18 237 89 0.49 (0.39-0.60) 7.5 (4.4-12.6) 
Prothrombin 20210G>A, n = 288 8324 28 0.34 (0.22-0.49) 5.2 (2.8-9.7) 

All P values were less than .001.

*

As concomitance of defects occurred frequently, relatives could be counted twice or more.

Adjusted for age, sex, and clustering in families and compared with relatives with no thrombophilic defects (n=951; 27 028 observation years; 12 events; annual incidence 0.05%; 95% CI, 0.02-0.08).